Oncologic outcomes and subsequent treatment following organ sparing surgery for penile carcinoma: The University of Texas M.D. Anderson Cancer Center Experience.

[1]  A. Sujenthiran,et al.  A study into the association between local recurrence rates and surgical resection margins in organ‐sparing surgery for penile squamous cell cancer , 2018, BJU international.

[2]  M. Kamel,et al.  Organ Sparing Surgery for Penile Cancer: A Systematic Review , 2017, The Journal of urology.

[3]  P. Spiess,et al.  Penile Sparing Surgery for Penile Cancer: A Multicenter International Retrospective Cohort , 2017, The Journal of urology.

[4]  K. Bilimoria,et al.  Centralization of Penile Cancer Management in the United States: A Combined Analysis of the American Board of Urology and National Cancer Data Base. , 2016, Urology.

[5]  G. Vespasiani,et al.  Sexual outcomes after partial penectomy for penile cancer: results from a multi-institutional study , 2015, Asian journal of andrology.

[6]  P. Karakiewicz,et al.  Development and external validation of a prognostic tool for prediction of cancer‐specific mortality after complete loco‐regional pathological staging for squamous cell carcinoma of the penis , 2015, BJU international.

[7]  Jie Yang,et al.  Glans preservation contributes to postoperative restoration of male sexual function: a multicenter clinical study of glans preserving surgery. , 2014, The Journal of urology.

[8]  N. Aaronson,et al.  Quality of life for patients treated for penile cancer. , 2014, The Journal of urology.

[9]  H. G. van der Poel,et al.  Penile sparing surgery for penile cancer-does it affect survival? , 2014, The Journal of urology.

[10]  D. Greene,et al.  Organ‐preserving surgery for penile cancer: description of techniques and surgical outcomes , 2012, BJU international.

[11]  R. Nigam,et al.  Conservative surgery for squamous cell carcinoma of the penis: resection margins and long-term oncological control. , 2012, The Journal of urology.

[12]  W. Mcdougal,et al.  Long-term outcome of excisional organ sparing surgery for carcinoma of the penis. , 2011, The Journal of urology.

[13]  R. Verhoeven,et al.  Incidence trends and survival of penile squamous cell carcinoma in the Netherlands , 2011, International journal of cancer.

[14]  M. Bader,et al.  Organ‐preserving neodymium‐yttrium‐aluminium‐garnet laser therapy for penile carcinoma: a long‐term follow‐up , 2010, BJU International.

[15]  S. Brandes,et al.  New developments in the treatment of localized penile cancer. , 2010, Urology.

[16]  S. Maddineni,et al.  Identifying the needs of penile cancer sufferers: A systematic review of the quality of life, psychosexual and psychosocial literature in penile cancer , 2009, BMC urology.

[17]  S. Horenblas,et al.  Recurrence patterns of squamous cell carcinoma of the penis: recommendations for follow-up based on a two-centre analysis of 700 patients. , 2008, European urology.

[18]  S. Brandes,et al.  Mohs micrographic surgery for penile cancer: management and long-term followup. , 2007, The Journal of urology.

[19]  C. Corbishley,et al.  Reconstructive surgery for invasive squamous carcinoma of the glans penis. , 2007, European urology.

[20]  A. Freeman,et al.  What surgical resection margins are required to achieve oncological control in men with primary penile cancer? , 2005, BJU international.

[21]  N. Bissada,et al.  Multi-institutional long-term experience with conservative surgery for invasive penile carcinoma. , 2003, The Journal of urology.

[22]  D. Zaak,et al.  Penile carcinoma. Is Nd:YAG laser therapy radical enough? , 2002, The Journal of urology.

[23]  N. Ananthakrishnan,et al.  The histological extent of the local spread of carcinoma of the penis and its therapeutic implications , 2000, BJU international.

[24]  A. Muneer,et al.  Glans resurfacing for the treatment of carcinoma in situ of the penis: surgical technique and outcomes. , 2011, European urology.

[25]  Cancer Facts & Figures 2021 , 2010 .

[26]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.